Evaluation of the mean cost and activity based cost in the diagnosis of pulmonary tuberculosis in the laboratory routine of a high-complexity hospital in Brazil

dc.creatorIsabela Neves de Almeida
dc.creatorLida Jouca de Assis Figueredo
dc.creatorValéria Martins Soares
dc.creatorMaria Cláudia Vater
dc.creatorSuely Alves
dc.creatorWânia da Silva Carvalho
dc.creatorAfrânio Lineu Kritski
dc.creatorSilvana Spindola de Miranda
dc.date.accessioned2025-04-08T11:18:40Z
dc.date.accessioned2025-09-09T00:54:07Z
dc.date.available2025-04-08T11:18:40Z
dc.date.issued2017-02-14
dc.description.sponsorshipCNPq - Conselho Nacional de Desenvolvimento Científico e Tecnológico
dc.description.sponsorshipFAPEMIG - Fundação de Amparo à Pesquisa do Estado de Minas Gerais
dc.format.mimetypepdf
dc.identifier.doihttps://doi.org/10.3389/fmicb.2017.00249
dc.identifier.issn1664-302X
dc.identifier.urihttps://hdl.handle.net/1843/81362
dc.languageeng
dc.publisherUniversidade Federal de Minas Gerais
dc.relation.ispartofFrontiers in microbiology
dc.rightsAcesso Aberto
dc.subjectTuberculose
dc.subject.otherAnálise de custos
dc.subject.otherSistema de saúde
dc.subject.otherMicobactérias
dc.subject.otherTecnologia
dc.subject.otherTuberculose
dc.titleEvaluation of the mean cost and activity based cost in the diagnosis of pulmonary tuberculosis in the laboratory routine of a high-complexity hospital in Brazil
dc.typeArtigo de periódico
local.citation.epage7
local.citation.spage1
local.citation.volume8
local.description.resumoAt a global level, with the increase in healthcare costs, there is a need to assess the economic impact of the incorporation of new technologies in different health disorders in different countries. There is scarce information regarding costs incurred with the use of current or new diagnostic tests for tuberculosis or from the vantage point of their incorporation within the healthcare systems of high-burden countries. The present study aimed to assess the mean cost and the activity based cost of the laboratory diagnosis for tuberculosis by means of conventional techniques and from the Detect TB®LabTest molecular test kit in a general high-complexity hospital of the public health system in Brazil. Cost analysis was performed by means of primary data, collected in the Mycobacteria and Molecular Biology Laboratory in 2013. The mean cost and activity based cost were, respectively, U$10.06/U$5.61 for centrifuged bacilloscopy by Ziehl Neelsen (ZN) and Auramine (AU); U$7.42/U$4.15 for direct bacilloscopy by ZN; U$27.38/U$16.50 for culture in a Loweinstein-Jensen solid medium; and U$115.74/U$73.46 for the Detect TB®LabTest Kit. The calculation of the ABC should be used in making decisions by administrators to be the best method of assessing the costs of conventional techniques and molecular method for providing the real value of the tests. So it is need to calculate the ABC, and not of the mean cost, in various scenarios before incorporating new technologies in health institutions.
local.publisher.countryBrasil
local.publisher.departmentFAR - DEPARTAMENTO DE FARMÁCIA SOCIAL
local.publisher.departmentMED - DEPARTAMENTO DE CLÍNICA MÉDICA
local.publisher.initialsUFMG
local.url.externahttps://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2017.00249/full

Arquivos

Pacote original

Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
Evaluation of the mean cost and activity based cost in the diagnosis of pulmonary tuberculosis in the laboratory routine of a high-complexity hospital in Brazil.pdf
Tamanho:
352.43 KB
Formato:
Adobe Portable Document Format

Licença do pacote

Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
License.txt
Tamanho:
1.99 KB
Formato:
Plain Text
Descrição: